Evidence map›Paper›PMID 33198099›Full record

ArticleMicroorganisms2020

Multidrug-Resistant

Andrey Shelenkov, Lyudmila Petrova, Valeria Fomina, Mikhail Zamyatin, Yulia Mikhaylova, Vasiliy Akimkin

Open access · goldAbstract read
In one paragraph

Article in Microorganisms, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Clinical microbiology reviews · 2025
    Review
  5. Article
  6. Genomic Epidemiology of Vancomycin-ResistantAntibiotics (Basel, Switzerland) · 2025
    Article
  7. Article
  8. Interaction of the SXT/R391 element ICEMicrobiology spectrum · 2025
    Article
  9. Article
  10. Emergence of β-lactamase-producingBiotechnology notes (Amsterdam, Netherlands) · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. A correlation study between virulence factors and multidrug resistance among clinical isolates of Proteus mirabilis.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2023
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Andrey ShelenkovCentral Research Institute of Epidemiology, Novogireevskaya str. 3a, 111123 Moscow, Russia.ORCID 0000-0002-7409-077X
Lyudmila PetrovaNational Medical and Surgical Center named after N.I. Pirogov, Nizhnyaya Pervomayskaya str., 70, 105203 Moscow, Russia.
Valeria FominaNational Medical and Surgical Center named after N.I. Pirogov, Nizhnyaya Pervomayskaya str., 70, 105203 Moscow, Russia.
Mikhail ZamyatinNational Medical and Surgical Center named after N.I. Pirogov, Nizhnyaya Pervomayskaya str., 70, 105203 Moscow, Russia.ORCID 0000-0002-2072-7798
Yulia MikhaylovaCentral Research Institute of Epidemiology, Novogireevskaya str. 3a, 111123 Moscow, Russia.
Vasiliy AkimkinCentral Research Institute of Epidemiology, Novogireevskaya str. 3a, 111123 Moscow, Russia.
Central Research Institute of Epidemiology · RUNational Medical and Surgical Center named after N.I. Pirogov · RU

Funding

Ministry of Science and Higher Education of the Russian Federation 075-15-2019-1666
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

antibiotic resistanceCRISPR-Cas systemhorizontal gene transferMDRphage genomeProteus mirabilis

Identifiers

PMID33198099
PMCPMC7696407
OpenAlexW3102514744

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.